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Abstract 
Cancer prevention by weight control via dietary calorie restriction (DCR) 
and/or exercise has been demonstrated in animal models. To understand the 
underlying mechanisms, we compared phorbol ester (TPA)-induced gene expression 
profiles in DCR- or exercise-treated mouse skin tissues. SENCAR mice were 
randomly assigned to one of the following four groups: ad libitum-fed sedentary 
control, ad libitum-fed exercise (AE), exercise but pair-fed at the amount of the 
control (PE), and 20% DCR. After 10-weeks, both body weight and fat composition 
significantly decreased in DCR and PE groups when compared with the controls. 
Weight loss was not observed in AE due to, at least in part, increased food intake. 
Among 39,000 transcripts with 45,101 probe sets measured by Affymetrix microarray, 
we identified TPA-induced 411, 110, and 67 genes that showed ≥ 1.5-fold and 
significant changed by DCR, AE, and PE, respectively. Of these significantly 
changed genes, gene ontology annotation showed a profound impact on gene 
expression by DCR in 21 biological process categories. Although PE and AE showed 
moderate impact on gene expression, the similarity of gene expression pattern altered 
by PE was relatively closer to DCR, while AE was closer to the control. The results 
of 22 cancer related gene expression pattern, especially for certain oncogenes, further 
supported that PE appeared to be a better alternative than AE to DCR-like cancer 
prevention. The impact on gene expression profile was associated with the effect on 
weight loss, i.e., DCR >> PE > AE. Overall, this study demonstrated for the first time 
that weight control via decreasing energy intake or increasing energy expenditure 
resulted in the different modes of gene expression. Furthermore, DCR showed 
profound inhibitory impact on the expression of genes relevant to cancer risks. 
Furthermore, exercise along with limited dietary calorie intake appears to be a better 
method for reducing weight and cancer risk when compared to exercise alone. 
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Introduction 
The National Health and Nutrition Examination Survey in 1999-2000 
indicates growing obesity rates in American adults over the past 20 years [1]. Case-
control and prospective cohort studies have identified obesity as a risk factor for 
many types of cancer including colon, breast, endometrial, kidney, and esophageal 
cancers [2]. High prevalence of overweight and obesity can be explained by a 
lifestyle characterized with over-consumption of calorie combined with low physical 
activity [3]. There is ample evidence that weight control via decreasing calorie intake 
and increasing physical activity reduces cancer risk. International Agency for 
Research in Cancer of the World Health Organization convened an International 
Working Group in 2001 and concluded that limiting weight gain during adult life 
reduces the risk of a number of different types of cancer and increasing physical 
activity prevents cancer [4].  
Studies conducted in animal models indeed demonstrated cancer prevention 
by weight control via dietary calorie restriction (DCR2) or exercise. DCR conducted 
in lean rodents was found to prevent many types of cancers, including mammary, 
liver, colon, skin, pancreas, and leukemia [5-10]. Exercise with or without DCR was 
also reported to have a potential protection against tumor incidence [11-14]. However, 
it was noted that exercise alone might not consistently result in cancer prevention [15-
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17]. 
Although the mechanisms of DCR and/or exercise for cancer prevention are 
not clear, some explanations such as alterations of hormone metabolism, hormone-
related cellular signaling, oxidation status, DNA repair, apoptosis and oncogene 
expression, etc. have been postulated [18-20]. Microarry analysis has been applied to 
cancer prevention experiments by DCR to explore the plausible mechanisms [21-28]. 
However, relative few data have been published regarding the comparison of gene 
expression between DCR and exercise, and to date there is no information concerning 
the gene expression profiles in the combination of dietary calorie intake and energy 
expenditure for cancer prevention. 
To determine the mechanisms underlying such complex relationships between 
body weight, calorie intake, physical activity, and cancer risk, we applied a genomic 
microarray analysis to the skin tissues of mice that were controlled in body weight by 
DCR, exercise, and exercise combined with limited calorie intake. The gene 
expression profiling was compared and certain phorbol ester-induced cancer-related 
genes were further exploited. 
 
Materials and Methods 
Animal and Animal Treatment: Fifty-two female SENCAR mice at 8 weeks 
of age with body weights averaged at 30±2 g were purchased from NIH (Frederick, 
MD). Mice were randomly assigned to one of the following four groups: ad libitum-
fed sedentary control, ad libitum-fed exercise (AE), exercise but pair-feeding at the 
amount as ad libitum-fed sedentary counterpart (PE), and 20% DCR. The 20% DCR 
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diet was formulated by the Harlan Teklad (Madison, WI), containing 20% less total 
calorie from carbohydrates and fat in comparison with the basal AIN-93 diet, and 
having extra protein and essential micronutrients to maintain a same level as the basal 
diet. The amount of the food that each control mouse consumed was recorded weekly 
and averaged to determine the amount of the following week for DCR and pair-
feeding consumption. A zero-grade, motor-driven, adjustable-speed rodent treadmill 
(Boston Gears, Boston, MA) was used to exercise the mice at 0.5 mph for 60 min per 
day, 5 days per week for 10 weeks. To take into account the biological clocks of 
nocturnal mice, we adjusted the light cycle to run nighttime exercise at 0400 to 0500 
h. The mice were put on a progressive training program starting at 10% of target 
exercise duration time and progressing to 100% of the target time by the end of the 
2nd week. Mice were housed individually in an environmentally controlled room 
maintained at 24 ± 0.6 ºC and 80% relative humidity with a 12 h light/12 h dark cycle 
starting at 1200 h. Body weights were recorded weekly. Body composition was 
monitored in the last week by a dual-energy X-ray absorptiometer scan (DXA) using 
small animal software (v5.6, Prodigy, Lunar-General Electric, Milwaukee, WI). At 
the end of the experiment when mice were about 20 weeks of age, the dorsal skin of 
the mice was shaved and topically treated once with TPA at 3.2 nmol. Mice were 
sacrificed two hours after TPA treatment. The 2-hr period of TPA treatment was 
selected based on a time course study reported previously by Przybyszewski et al. 
(29). The dorsal skin samples were snap-frozen in liquid nitrogen and kept at -80 ºC 
until further analyses. 
Microarray Analysis:  Microarray analysis was processed by the Microarray 
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Core of the Mental Retardation Research Center at the University of Kansas Medical 
Center (Kansas City, KS). Four mice from each treatment group were used to obtain 
mouse skin tissues. Each mouse skin tissue (0.4 µg) was homogenized in 1 mL 
TRIZOL reagent and the total RNA was extracted and precipitated by chloroform and 
isopropanal. Pellet RNA was dissolved in DEPC water and further purified by using 
the RNeasy cleanup kit (Qiagen, Valeacia, CA). The quantity and quality of RNA 
were measured by using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo 
Alto, CA). Ten µg of total RNA were then annealed with 100 pmol of T7(dT)24 at 70 
ºC for 10 min. The annealed mRNA was reverse transcribed into cDNA using the 
Superscript Choice System kit (Invitrogen Corp., Carlsbad, CA). Biotinylated 
antisense cRNA was prepared using the Enzo BioArray High Yield RNA Labeling kit 
(Enzo Diagnostics, Farmingdale, NY). After purification of labeled cRNA using 
RNeasy RNA Purification Mini kit (Qiagen, Valencia, CA), 20 µg biotin labeled 
cRNA was incubated in fragmentation buffer (40 mM of Tris-Acetate, 100 mM of 
potassium acetate, 30 mM of magnesium acetate, pH 8.1) at 94 ºC for 35 min. The 
labeled cRNA then was applied to a GeneChipPR P Mouse Genome 430 2.0 Array 
(Affymetrix, Santa Clara, CA), containing 39,000 transcripts with 45,101 probe sets. 
The GeneChip was hybridized, washed, and scanned using Affymetrix equipment and 
protocols.  
Microarray Data Analysis: Microarray images were quantified by using 
GeneChip operating software 1.0 (GCOS 1.0, Affymetrix, Santa Clara, CA). The 
detection calls of the probe sets were determined using default settings (α1, 0.04; α2, 
0.06; δ, 0.015; scale factor, 1.0; norm factor, 1.0). GeneSpring software (TAgilent 
Technologies, Palo Alto, CA) and Access Database (Microsoft Windows) were used 
to do data analysis. Scatter plot and condition trees are analyzed by the GeneSpring 
Software, and distance of gene expression profile were obtained from GeneSpring 
and compared among groups. Data were first scaled to the same average intensity 
among all chips to allow fair comparison. Two-step Normalizations were used, 
including per chip normalization (normalization to 50  percentile) and per gene 
normalization from which the signal intensity in a given chip is divided by the 
average intensity of the same gene across all chips. According to their expression 
levels, a discrimination score of a given probe set was calculated based on: R = (PM-
MM)/(PM+MM), while R is discrimination scare, PM is perfect match, and MM is 
mismatch. The distance between the discrimination score and the given 
discrimination threshold were tested using One-sided Wilcoxon’s Signed Rank test. 
Probe sets with p-value lower than 0.04 were considered present (P); those with p-
value greater than 0.06 were absent (A); and those with p-value in between 0.04 and 
0.06 were marginal (M). Furthermore, some microarray data as marked with _x _at 
suffixes are not unique probe sets or not identical probes among multiple transcripts. 
Therefore, we excluded all the A, M, and _x _at probe data to increase the data 
accuracy and reliability. Fold change at 1.5 was used as a cut off to filter 
experimental data compare with control group. Then ANOVA with Dunnett’s’ 
adjustment was applied to assess gene expression difference between the treatment 
and the control groups. Finally, gene ontology (GO) Slims 
(http://www.geneontology.org/GO.slims.shtml) were applied to classify the 
differentially expressed genes into 21 GO categories based on the major biological 
th
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processes. The categories of TPA-induced cancer related genes including tumor 
suppressor, apoptosis inducer, apoptosis inhibitor, and oncogene were further 
presented. 
RT-PCR Confirmation: RT-PCR reaction was carried out by using purified 
total RNA obtained as described above. The cDNA was synthesized by RT-PCR 
using one-step RT-PCR kit (Qiagen, Valeacia, CA). The primers are derived from 
published gene sequences as follows: MAPK1: sense primer 5'-TCT CCC GCA CAA 
AAA TAA GG-3', antisense primer 5'-TCG TCC AAC TCC ATG TCA AA-3'; H-ras: 
sense primer 5’-TGT TAC CAA CTG GGA CGA CA-3’, antisense primer 5’-TCT CAG 
CTG TGG TGG TGA AG-3’; PI3Kca: sense primer 5'-TGT TTG CAA AGA AGC TGT 
GG-3', antisense primer 5'-TAT GAC CCA GAG GGA TTT CG-3'; IGFBP3: sense 
primer 5’-AAG TTC CAT CCA CTC CAT GC-3’, antisense primer 5’-AGC TCT GCT 
TTC TGC CTT TG-3’; lepr: sense primer 5'-AGG CCC AGA CAT TTT TCC TT-3', 
antisense primer 5'-TCC TGG AGG ATC CTG ATG TC-3'; β-actin: sense primer 5’-
TGT TAC CAA CTG GGA CGA CA-3’, antisense primer 5’-TCT CAG CTG TGG TGG 
TGA AG-3’. Fifty µL of PCR reaction were run with a final concentration of 200 µM 
of dNTP mix, 1 x PCR buffer, 1 µM of each primer, and 1.0 U of Taq polymerase. 
Thermal cycling conditions, following an initial denaturation at 94 °C for 4 min, were 
as follows: 30 sec at 95 °C, annealing at 55 °C for 30 sec, and extension at 72 °C for 
1 min. Then samples were incubated at 72 °C for 7 min. Amplified products at 8 µL 
were loaded and separated on a 1.5% agarose gel. The RT -PCR products were 
visualized under UV light by the FluorChemPTMP 8800 Advanced Imaging System 
(Alpha Innotech, San Leandro, CA). The relative density of the target band was 
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normalized to the loading control β-actin and then expressed as a percentage of the 
controls. 
Statistic Analysis: The overall effects of treatments on body weight, fat 
composition, and RT-PCR expression levels were analyzed by one-way ANOVA, and 
then Dunnett’s method and least significant difference (LSD) were used to assess the 
differences between the treatment groups and the control group. The statistical 
significance of difference was set at P ≤ 0.05. 
 
Results 
Impact on body weight and body fat composition: Lean adult SENCAR 
mice in the control group gradually gained weight throughout the experimental period, 
while mice at 20% DCR or exercise with pair-feeding consistently lost weight. By the 
end of the experiment, the weights of DCR and PE mice were significantly lower than 
the control mice (Figure 1A). Exercise with ad libitum feeding (AE) did not lower 
weight significantly when compared with the sedentary counterparts, which might be, 
at least in part, due to the increased food intake (4.0 ± 0.2 g/day for the control mice 
vs. 4.3 ± 0.4 g/day for AE mice). Consequently, percent fat composition, as shown in 
Figure 1B, significantly decreased in PE and DCR groups but not AE group when 
compared with the controls. No significant change of bone density was found among 
groups (data not shown). 
TPA-induced gene expression profiles in response to DCR and exercise 
treatments: We measured 45,101 gene probe sets expressed in the skin tissues of the 
DCR-fed or exercise-treated mice. We compared the distribution of the scatter plots 
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among AE, PE, and DCR and found that DCR treatment produced the most extensive 
range of the gene expression levels. A condition tree by using Hierarchical clustering 
method further displayed the similarity of gene profiles as indicated by a distance 
between two groups. The smaller the distance is, the closer the gene expression 
profiling between two groups. Since the results showed a distance at 0.27 between 
DCR and PE, 0.69 between AE and the control, and 0.96 between DCR and AE, we 
were convinced that the gene expression pattern of PE group was relatively similar to 
that of DCR, while AE was closer to the control. 
TPA-induced expression of genes regulated by DCR or exercise 
treatments: We identified 559 genes that showed at least 1.5-fold significant change 
(P ≤ 0.05) by either DCR or exercise treatment when comparing with the control. As 
shown in Figure 2, we recognized that 411 genes (97 suppressed and 314 over-
expressed) were altered by DCR, 110 genes (71 suppressed and 39 over-expressed) 
were changed by AE, and 67 genes (22 suppressed and 45 over-expressed) were 
regulated by PE, respectively. It should be noted that two genes relating to RIKEN 
cDNA (AK009351) and plasmalemma vesical associated protein (NM032398) were 
down-regulated in both AE and DCR groups, and 6 genes including RIKEN mRNA 
sequence (BB143476), MARCKS-like protein (NM010807), major urinary protein 3 
(M27608), sortilin 1 (AV247637), endothelin receptor B (BB770914), and ATPase 
(BC001995) were down-regulated in both PE and DCR groups. It was interesting that 
only one gene corresponding to sequence AA407809 was over-expressed in both AE 
and PE groups, but 20 genes such as casein kinase II (BG070990), forming binding 
protein 2 (BB817145), adenylate cyclase 1 (AI848263), sperm associated antigen 1 
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(NM012031), sialyltransferase 10 (NM018784), SH3 domain protein D19 
(NM012059), cystathionine beta-synthase (BC026595), galactosylceramide 
sulfotransferase (AK002510), and proline dehydrogenase (NM011172) were over-
expressed in both PE and DCR groups.  
Functional over-representation analysis: Functional over-representation 
analysis by GO annotation was performed to identify major biological processes 
potentially impacted by the treatments. Figure 3 shows 21 GO categories that were 
significantly impacted by either calorie restriction or exercise with the percentage of 
each treatment-induced gene expression frequency. Of the significantly changed 
genes, DCR showed considerable impact for account of ~ 80% when compared with 
PE or AE that was usually less than 20%. Specifically, the most genes identified in 
our study are involved in cell growth/maintenance and cell communication categories, 
following by DNA binding, transcription factor activity, and transcription categories. 
A list of all the genes that significantly changed by either DCR or exercise treatment 
with GO category classification has been provided as a supplementation file. 
RT-PCR confirmation: the microarray data were further validated by using 
RT-PCR for five randomly selected genes in cancer-related categories. As shown in 
Figure 4, five representative gels respectively showed the expression patterns of five 
genes in comparison with β-actin as a loading control. Given these RT-PCR data, we 
found the gene expression of MAPK1, PI3Kca and IGFBP3 was significantly 
decreased in DCR group in comparison with the control group. Both H-ras and lepr 
were not significantly changed between experimental groups. The RT-PCR 
confirmation rate to the microrray data set, as estimated by using a Bayesian 
statistical method, is about 93.3%.  
Impact on TPA-induced cancer-related genes: Apart from the genes 
relevant to nutrient metabolisms and other biological processes, we further identified 
22 genes related to TPA-induced cancer risk by using the GO Slims. As shown in 
Table 1, we found that DCR induced over-expression of 3 tumor suppressor genes, 4 
apoptosis inducers, and one apoptosis inhibitor. DCR also induced down-expression 
of two apoptosis inducers and 8 oncogenes. In comparison with DCR, the impact of 
PE on expression of these genes is moderate, which induced down-regulation of one 
apoptosis inducer gene and 4 oncogenes and up-regulation of one apoptosis inducer 
gene. In contrast, AE was associated with down-expression of one apoptosis inducer 
gene and one oncogene, but up-expression of one apoptosis inhibitor gene and one 
oncogene. 
 
Discussion 
Weight control can be achieved by either reducing energy intake such as DCR 
or enhancing energy expenditure like exercise. While 20% DCR reduced body weight 
significantly, which corresponded to decreased fat composition, the treadmill exercise 
under this experimental condition demonstrated only a modest weight loss. Exercise 
alone with ad libitum feeding was not sufficient for decreasing body weight due to, at 
least in part, the corresponding increase in diet intake. If the food intake of the 
exercised mice was limited by pair-feeding with their sedentary counterpart, then 
body weight and fat composition were modestly but significantly reduced. It should 
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be noted that the interaction of dietary and physical activity upon energy expenditure 
and homeostasis is complicated. In addition to dietary energy intake and physical 
activity, for example, the thermogenesis responsible to dietary change and the energy 
expenditure required for performance of cellular function may also play an interactive 
role in weight change [30]. 
By using our established strategies to control body weight in SENCAR mice, 
we measured the genomic gene expression in TPA-promoted skin tissues and 
compared the TPA-induced gene expression profiles among AE, PE, and DCR 
treatments. Of the 39,000 transcripts with 45,101 probe sets measured, we identified 
559 genes that showed at least 1.5-fold significant change by DCR and/or exercise 
treatments in comparison with the controls. The 1.5-fold significant change was 
selected since it showed a consistent result with a relatively large expression and 
conservative level [22, 31]. However, the cut off line at 1.5-fold change may exclude 
genes with <1.5 fold but significantly altered their expression by the treatments. 
Of these 559 genes, 411 genes (97 down-expression and 314 over-expression) 
were altered by DCR, 110 genes (71 down and 39 over) were changed by AE, and 67 
genes (22 down and 45 over) were changed by PE, respectively. It is interesting to 
note the function of some specific genes that were co-regulated significantly by both 
DCR and PE groups. For example, the gene encoding MARCKS (Myristoylated 
Alanine-Rich C Kinase Substrate) protein was down-expressed significantly in both 
PE and DCR groups but not AE group. MARCKS protein is a widely distributed 
substrate for protein kinase C [32] and activation of protein kinase C has been well 
recognized as an initial signal in TPA-induced tumor promotion in mouse skin 
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carcinogenesis [33]. In addition, an up-regulation of histone deacetylase 11 gene 
(BC016208), one of the large family of sirtunis including SIRT1, by DCR group is in 
agreement with the published reports by Cohen et al. [34]. Furthermore, SIRT1 has 
been found to be required for the increased physical activity that is typically observed 
in calorie restricted mice [35]. 
When compared with DCR treatment that provides a profound impact on gene 
expression, the number of gene expression altered by PE and AE are moderate. 
However, the similarity of gene expression pattern altered by PE and AE appears 
considerably different. The results by condition tree analysis indicate that the gene 
expression pattern altered by PE treatment is relatively closer to DCR, while AE is 
closer to the control. This suggests that moderate exercise alone without diet control 
may have little effect on DCR-like gene expression pattern. The combination of 
aerobic exercise with diet control, however, not only lowered body weight but also 
provided a DCR-like impact on gene expression pattern. This observation is further 
supported by the results of GO annotation analysis. 
By using GO annotation, we identified all the altered genes in 21 GO 
categories for major biological processes. Specifically, we listed 22 genes that are 
classified into four TPA-induced cancer-related categories. It is not unexpected that 
DCR provides an overwhelming impact on the expression of these cancer-related 
genes, generally in favor of cancer prevention by inducing over-expression of tumor 
suppressor and apoptosis inducer genes as well as down-expression of oncogenes. It 
is interesting that PE induced a moderate, but similar impact as DCR on oncogene 
expression, especially in down-regulating the oncogenes. In contrast, AE showed the 
 14
least impact on these cancer related genes. Considering the impact on body weight 
and fat composition as well as the similarity of gene expression pattern, we may 
deduce that PE could be a better alternative than AE to DCR-like cancer prevention 
via modifying gene expression pattern such as down-regulation of certain oncogenes. 
Frankly speaking, it is challenging and ambitious to specify all the 
significantly changed genes and their potential roles accounted for cancer prevention. 
Although microarray analysis is useful for identifying potential gene expression and 
enhance our understanding of the cancer prevention by weight control, future studies 
by incorporating gene expression data with proteomics may provide more insights. 
Nevertheless, this pilot study reports the altered mRNA expression of certain 
genes in weight control mice via either reduced dietary energy intake or increased 
energy expenditure. DCR treatment provided substantial weight loss and significantly 
modified the gene expression profile. PE induced a modest impact on both weight 
loss and gene expression. In contrast to PE, AE was not associated with reduced body 
weight and its effect on gene expression pattern was more similar to the controls. The 
data suggest that the degree of weight loss may be the critical indicator in reducing 
cancer risks. 
 
Acknowledgements 
We acknowledge the DXA analysis assistance of Dr. Mark Haub (Department 
of Human Nutrition, Kansas State University), the computational advice of Dr. 
Kesheng Liu (Department of Plant Pathology, Kansas State University), and the 
assistance in microarray data analysis from Mrs. Nanyan Weng (Gene Expression 
 15
Facility, Kansas State University). This study is supported by an Innovative Research 
Grant from the Terry Johnson Center for Basic Cancer Research, Kansas State 
University, grant COBRE P20 RR15563, and grant R01 CA106397 from the National 
Institute of Health. This is a journal contribution # 04-429-J of the Kansas Agriculture 
Experiment Station, Manhattan, Kansas.
 16
References: 
1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity  
among US adults, 1999-2000. J Am Med Assoc 288:1723-1727, 2002. 
2.  Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 
3:565-574, 2002. 
3. Scott MG. Multifactorial causation of obesity: implications for prevention. Am J Clin 
Nutr 67: 563S-572S, 1998. 
4.  Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer 
prevention: international evaluation of the evidence. Eur J Cancer Prev 2:S94-100, 2002. 
5. Kritchevsky D. Caloric restriction and experimental mammary carcinogenesis. Breast 
Cancer Res Treat 46:161-167, 1997. 
6. Kolaja KL, Bunting KA, Klaunig JE. Inhibition of tumor promotion and hepatocellular 
growth by dietary restriction in mice. Carcinogenesis 17:1657-1664, 1996. 
7. Pollard M, Luckert PH, Pan GY. Inhibition of intestinal tumorigenesis in 
methylazoxymethanol-treated rats by dietary restriction. Cancer Treat Rep 68:405-408, 
1984. 
8. Birt DF, Pinch HJ, Barnett T, Phan A, Dimitroff K. Inhibition of skin tumor promotion 
by restriction of fat and carbohydrate calories in SENCAR mice. Cancer Res  53:27-31, 
1993. 
9. Robuck BD, Yager JD, Longnecker DS. Dietary modulation of azaserine-induced 
pancreatic carcinogenesis in the rat. Cancer Res 41:888-93, 1981. 
10. Yoshida K, Inoue T, Nojima K, Hirabayashi Y, Sado T. Calorie restriction reduces the 
incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice. 
 17
 18
Proc Natl Acad Sci USA 94:2615-2619, 1997. 
11. Kritchevsky D. Influence of caloric restriction and exercise on tumorigenesis in rats. Proc 
Soc Exp bio Med 193:35-38, 1990. 
12. Davis JM, Kohut ML, Jackson DA, Colbert LH, Mayer EP, Ghaffar A. Exercise effects 
on lung tumor metastases and in vitro alveolar macrophage antitumor cytotoxicity. Am J 
Physiol  274:R1454-1459, 1998. 
13. Hoffman-Goetz L, May KM, Arumugam Y. Exercise training and mouse mammary 
tumor metastasis. Anticancer Res 14:2627-2631, 1994. 
14. Lane HW, Teer P, Keith RE, White MT, Strahan S. Reduced energy intake and moderate 
exercise reduce mammary tumor incidence in virgin female BALB/c mice treated with 
7,12-dimethylbenz(α) anthracene. J Nutr 121:1883-1888, 1991. 
15. Thompson HJ, Ronan AM, Ritacoo KA, HT agliaferro ARTH, HTMeeker LDTH. Effect of exercise 
on the induction of mammary carcinogenesis. Cancer Res 48:2720-2723, 1988. 
16. Thompson HJ, Ronan AM, Ritacoo KA, Tagliaferro AR. Effect of type and amount of 
dietary fat on the enhancement of rat mammary tumorigenesis by exercise. Cancer Res 49: 
1904-1908, 1989. 
17. Thompson HJ, Westerlind K, HTSnedden JRTH, HTBriggs STH, HTSingh M TH. Inhibition of mammary 
carcinogensis by treadmill exercise. J Natl Cancer Inst 87: 453-455, 1995. 
18. HTKritchevsky DTH. Caloric restriction and experimental carcinogenesis. Hybrid Hybridomics 
21:147-151, 2002. 
19. Zhu Z, Jiang W, Thompson HJ. Mechanism by which energy restriction inhibits rat 
mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in 
mammary carcinomas. Carcinogenesis 24:1225-1231, 2003. 
20. Rogers AE, Zeisel SH, Groopman J. Diet and carcinogenesis. Carcinogenesis 14:2205-
2217, 1993. 
21. Cao SX, Dhahbi JM, Mote PL, Spindler SR. Genomic profiling of short- and long- term 
caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci USA 98:10630-
10635, 2001. 
22. Dhahbi JM, Kim HJ, Mote PL, Beaver RJ,  Spindler SR. Temporal linkage between the 
phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci USA 101: 
5524-5529, 2004. 
23. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its 
retardation by caloric restriction. Science 285:1390-1393, 1999. 
24. Jevis KM, Robaire B. Effects of caloric restriction on gene expression along the 
epididymis of the Brown Norway rat during aging. Exp Gerontol 38:549-60, 2003. 
25. Tsuchiya T, Dhahbi JM, Cui X, Mote PL, Bartke A, Spindler SR. Additive regulation of 
hepatic gene expression by dwarfism and caloric restriction. Physiological Genomics 17: 
307-315, 2004. 
26. Higami Y, Barger JL, Page GP, Allison DB, Smith SR, Prolla TA, Weindruch R. Energy 
restriction lowers the expression of genes linked to inflammation, the cytoskeleton, the 
extracellular matrix, and angiogenesis in mouse adipose tissue. J Nutr 136:343-352, 2006. 
27. Sreekumar R, Unnikrishnan J, Fu A, Nygren J, Short KR, Schimke J, Barazzoni R, Nair 
KS. Effects of caloric restriction on mitochondrial function and gene transcripts in rat 
muscle. Am J Physiol Endocrinol Metab 283:E38-43, 2002. 
28. Han ES, Hickey M. Microarray evaluation of dietary restriction. J Nutr 135:1343-1346, 
2005. 
 19
29. Przybyszewski J, Yaktine AL, Duysen E, Blackwood D, Wang W, Au A, Birt DF. 
Inhibition of phorbol ester-induced AP-1-DNA binding, c-Jun protein and c-jun mRNA 
by dietary energy restriction is reversed by adrenalectomy in SENCAR mouse epidermis. 
Carcinogenesis 22:1421-1427, 2001. 
30. Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. 
Science 307:1909-1914, 2005. 
31. Petersen D, Chandramouli GV, Geoghegan J, Hilburn J, Paarlberg J, Kim CH, Munroe D, 
Gangi L, Han J, Puri R, Staudt L, Weinstein J, Barrett JC, Green J, Kawasaki ES. Three 
microarray platforms: an analysis of their concordance in profiling gene expression. 
BMC Genomics 6:63, 2005. 
32. Stumpo DJ, Eddy RL Jr, Haley LL, Sait S, Shows TB, Lai WS, Young WS 3rd, Speer 
MC, Dehejia A, Polymeropoulos M, Blackshear PJ. Promoter sequence, expression, and 
fine chromosomal mapping of the human gene (MLP) encoding the MARCKS-like 
protein: identification of neighboring and linked polymorphic loci for MLP and MACS 
and use in the evaluation of human neural tube defects. Genomics 49:253-264, 1998. 
33. Wheeler DL, Ness KJ, Oberley TD, Verma AK. Protein kinase Cepsilon is linked to 12-
O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain 
shedding and the development of metastatic squamous cell carcinoma in protein kinase 
Cepsilon transgenic mice. Cancer Res 63:6547-6555, 2003. 
34. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, 
Gorospe M, de Cabo R, Sinclair DA. Calorie restriction promotes mammalian cell 
survival by inducing the SIRT1 deacetylase. Science 305:390-392, 2004. 
35. Chen D, Steele AD, Lindquist S, Guarente L. Increase in activity during calorie 
 20
restriction requires Sirt1. Science 310:1641, 2005. 
 21
 22
Figure legends: 
Figure 1: Effects of DCR and exercise-treatment on body weight and fat composition. A: 
body weight; B: fat composition. Results are means ± SE, n=8-12. Means with different 
alphabetical letters differ significantly, p ≤ 0.05. 
Figure 2: Venn diagram with number of genes altered in each group, shared across two 
groups, and shared across all three groups. Left: Genes that are 1.5-fold significantly down-
expressed in comparison with the control, Right: Genes that are 1.5-fold significantly over-
expressed in comparison with the control.  
Figure 3: Functional over-representation analysis of gene expression altered by DCR and 
exercise treatments. Gene ontology Slims were used to show the percentage of TPA-induced 
gene expression altered by AE, PE, and DCR, respectively, with a given gene ontology category. 
Each gene category shown is the combined genes that are significantly altered (p<0.05) at greater 
than 1.5 fold change. The number of genes for each category is shown in parenthesis. 
Figure 4: Confirmation of microarray data by RT-PCR. Five genes were randomly chosen 
from cancer-related categories, and their expression pattern in comparison with the microarray 
data was validated by RT-PCR. Identical results were obtained with MAPK1, PI3Kca, and 
IGFBP3 genes that down-expressed significantly in DCR group. The expression of β-actin gene 
was used as a loading control. 
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Table 1. Identified phorbol ester-induced cancer related genes altered by DCR, PE, and AE 
treatments, respectively. 
Fold Change (p value)* Ontology 
Category 
Probe Gene Name 
DCR PE AE 
1429418_at RIKEN cDNA A530086E13 gene +1.52 
(p<0.036) 
  
1418146_a_at retinoblastoma-like 2 +1.61 
(p<0.030) 
  Tumor 
Suppressor 1454867_at Mus musculus transcribed sequence with 
moderate similarity to protein sp:Q10571 
(H.sapiens) MN1_HUMAN Probable tumor 
suppressor protein MN1 
+1.70 
(p<0.024) 
  
1449317_at CASP8 and FADD-like apoptosis regulator -2.91 
(p<0.002) 
-1.62 
(p<0.002) 
 
1418011_a_at SH3-domain GRB2-like B1 (endophilin) +1.52 
(p<0.029) 
  
1450731_s_at tumor necrosis factor receptor superfamily, 
member 21 
+1.96 
(p<0.026) 
+1.80 
(p<0.026) 
 
1433938_at transformation related protein 53 binding 
protein 2 
+1.72 
(p<0.025) 
  
1449591_at caspase 4, apoptosis-related cysteine 
protease 
+1.59 
(p<0.014) 
 -1.81 
(p<0.045) 
Apoptosis 
Inducer 
1426184_a_at Programmed cell death 6 interacting protein -2.12 
(p<0.042) 
  
1449033_at tumor necrosis factor receptor superfamily, 
member 11b (osteoprotegerin) 
+2.31 
(p<0.031) 
+1.98 
(p<0.031) 
 
Apoptosis 
Inhibitor 1435024_at nucleolar protein 3 (apoptosis repressor 
with CARD domain) 
  +1.58 
(p<0.035) 
1422687_at neuroblastoma ras oncogene -1.98 
(p<0.034) 
  
1451715_at v-maf musculoaponeurotic fibrosarcoma 
oncogene family, protein B (avian) 
 -1.64 
(p<0.008) 
 
1427783_at v-erb-a erythroblastic leukemia viral 
oncogene homolog 4 (avian) 
-3.34 
(p<0.033) 
-2.47 
(p<0.033) 
-1.69 
(p<0.033) 
1417155_at neuroblastoma myc-related oncogene 1 -3.31 
(p<0.008) 
-1.93 
(p,0.008) 
 
1424332_at Rab40c, member RAS oncogene family -2.64 
(p<0.010) 
  
1417656_at myeloblastosis oncogene-like 2 -2.18 
(p<0.001) 
-1.64 
(p<0.001) 
 
1422087_at lung carcinoma myc related oncogene 1 -2.02 
(p<0.007) 
  
1450194_a_at myeloblastosis oncogene -1.95 
(p<0.040) 
 +1.67 
(p<0.040) 
1422119_at RAB5B, member RAS oncogene family -1.88 
(p<0.035) 
  
1448885_at RAP2B, member of RAS oncogene family -1.70 
(p<0.006) 
  
Oncogene 
1416591_at RAB34, member of RAS oncogene family -1.52 
(p<0.035) 
  
 
* The fold change is a ratio of the gene expression in the treatment group to the controls, which 
is denoted as increased (+) or decreased (-) if the treatment group is greater or less than the 
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control, respectively. Only the data that are greater or less than 1.5-fold with a significant change 
(p < 0.05) are present (n = 4 per group). 
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